Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -288.14% is 88% below its 5-year average of -152.87%, around the middle of its 5-year range (-817.19%–-50.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.70% below its 12-month average of -185.06%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -288.14%.
RETURN ON INVESTED CAPITAL (ROIC)
-288.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-185.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-202.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-152.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-131.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-55.70%
CURRENT VS 3Y AVG
-42.31%
CURRENT VS 5Y AVG
-88.49%
CURRENT VS 10Y AVG
-118.53%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
-900.99%
vs the sector median at left
Aptevo Therapeutics Inc.
Market Cap
$3.94M
Return on Invested Capital (ROIC)
-288.14%
TTM Avg
-185.06%
3Y Avg
-202.46%
5Y Avg
-152.87%
Market Cap
$4.18M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-199.78%
3Y Avg
-1598.70%
5Y Avg
-1598.70%
Market Cap
$3.59M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.32M
Return on Invested Capital (ROIC)
-116.89%
TTM Avg
-117.72%
3Y Avg
-83.78%
5Y Avg
-61.46%
Market Cap
$3.48M
Return on Invested Capital (ROIC)
-130.12%
TTM Avg
-72.08%
3Y Avg
-61.96%
5Y Avg
-55.38%
Market Cap
$3.47M
Return on Invested Capital (ROIC)
-184.27%
TTM Avg
-194.39%
3Y Avg
-144.44%
5Y Avg
-112.27%
Market Cap
$4.41M
Return on Invested Capital (ROIC)
-346.94%
TTM Avg
-467.60%
3Y Avg
-296.93%
5Y Avg
-277.74%
Market Cap
$4.42M
Return on Invested Capital (ROIC)
-221.32%
TTM Avg
-119.11%
3Y Avg
-77.97%
5Y Avg
-64.48%
Market Cap
$3.44M
Return on Invested Capital (ROIC)
-133.29%
TTM Avg
-160.18%
3Y Avg
-147.91%
5Y Avg
-122.63%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $3.94M | -288.14% | -185.06% | -202.46% | -152.87% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | -199.78% | -1598.70% | -1598.70% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -116.89% | -117.72% | -83.78% | -61.46% |
| Evogene Ltd. (EVGN)vs › | $3.48M | -130.12% | -72.08% | -61.96% | -55.38% |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | -184.27% | -194.39% | -144.44% | -112.27% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -346.94% | -467.60% | -296.93% | -277.74% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -221.32% | -119.11% | -77.97% | -64.48% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | -133.29% | -160.18% | -147.91% | -122.63% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | -246.61% | -463.24% | -303.42% | -359.05% |
ROIC
-288.1%
ROE
-437.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -288.14% |
| 2026-03-31 | -166.33% |
| 2025-12-31 | -119.55% |
| 2025-09-30 | -124.86% |
| 2025-06-30 | -226.41% |
| 2025-03-31 | -817.19% |
| 2024-12-31 | -262.17% |
| 2024-09-30 | -265.59% |
| 2024-06-30 | -273.12% |
| 2024-03-31 | -248.05% |
| 2023-12-31 | -163.92% |
| 2023-09-30 | -148.72% |
| 2023-06-30 | -142.73% |
| 2023-03-31 | -105.53% |
| 2022-12-31 | -104.12% |
| 2022-09-30 | -96.48% |
| 2022-06-30 | -64.99% |
| 2022-03-31 | -86.26% |
| 2021-12-31 | -63.86% |
| 2021-09-30 | -56.50% |
| 2021-06-30 | -50.07% |
| 2021-03-31 | -53.98% |
| 2020-12-31 | -62.48% |
| 2020-09-30 | -94.61% |
| 2020-06-30 | -284.08% |
| 2020-03-31 | -212.47% |
| 2019-12-31 | -121.59% |
| 2019-09-30 | -112.71% |
| 2019-06-30 | -101.06% |
| 2019-03-31 | -79.30% |
| 2018-12-31 | -103.57% |
| 2018-09-30 | -86.46% |
| 2018-06-30 | -69.83% |
| 2018-03-31 | -58.17% |
| 2017-12-31 | -46.53% |
| 2017-09-30 | -52.02% |
| 2017-06-30 | -161.76% |
| 2017-03-31 | -148.20% |
| 2016-12-31 | -175.55% |
| 2016-09-30 | -135.36% |
| 2016-06-30 | -56.87% |
| 2016-03-31 | -51.25% |
| 2015-12-31 | -66.04% |
